5月7日，吉利德科学(GILD)盘中下跌5.02%，截至01:55，报97.645美元/股，成交5.47亿美元，总市值1215.68亿美元。
财务数据显示，截至2025年03月31日，吉利德科学收入总额66.67亿美元，同比减少0.28%；归母净利润13.15亿美元，同比增长131.53%。
资料显示，吉利德科学公司是一家研究型生物制药公司,其使命在于发现并满足医疗领域的需求,开发和商业化创新药物。 该公司努力简化对于世界各地各种疾病的治疗。 吉利德的产品组合和研发药物包括治疗艾滋病毒/艾滋病,肝脏疾病,癌症,炎症和呼吸系统疾病以及心血管疾病。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.